The Effect of Thioredoxin on the Expression of Proopiomelanocortin-Derived Peptides, the Melanocortin 1 Receptor and Cell Survival of Normal Human Keratinocytes  by Funasaka, Yoko et al.
The Effect of Thioredoxin on the Expression of
Proopiomelanocortin-Derived Peptides, the Melanocortin 1
Receptor and Cell Survival of Normal Human Keratinocytes
Yoko Funasaka, Ashok K. Chakraborty, Junji Yodoi,* and Masamitsu Ichihashi
Department of Dermatology, Kobe University School of Medicine, Kobe, Japan; *Institute for Virus Research, Kyoto University, Kyoto, Japan
An important constituent of the cellular antioxidant
buffering system that controls the redox state of
proteins is thioredoxin (TRX), a 13 kDa protein that
catalyzes thiol-disul®de exchange reactions, regulates
activation of transcription factors, and possesses
several other biologic functions similar to cytokines.
We have previously reported that TRX released from
UVB-irradiated keratinocytes stimulates melano-
genesis by upregulating MSH receptor expression
and its binding activity in melanocytes. The purpose
of this study was to examine the effects of TRX on
keratinocytes as an autocrine factor. TRX suppressed
the UVB-induced production and secretion of
a-melanocyte stimulating hormone (a-MSH) and of
adrenocorticotropic hormone (ACTH), and also sup-
pressed proopiomelanocortin (POMC) mRNA
expression by normal human keratinocytes; however,
TRX upregulated melanocortin 1 receptor (MC1-R)
expression synergistically with UVB in normal
human keratinocytes. These results suggest that exo-
genous TRX regulates expression of those genes in
different manners. Furthermore, addition of an anti-
body against TRX induced cell death in keratino-
cytes, probably due to enhanced signaling of MSH,
as it has been shown that MSH suppresses heat shock
protein (hsp) 70 expression in differentiated keratino-
cytes, which express high levels of MC1-R and
decreases their survival rate during oxidative stress.
Taken together, the results suggest that keratinocyte-
derived TRX regulates the expression of stress indu-
cible neuropeptides and their receptor, and is critic-
ally involved in the survival of keratinocytes. Key
words: cell death/Mc1-R/MSH/POMC. Journal of
Investigative Dermatology Symposium Proceedings 6:32±37,
2001
T
hioredoxin (TRX) is a small multifunctional protein
with a redox-active disul®de/dithiol motif within a
conserved active site sequence -Cys-Gly-Pro-Cys-
(Holmgren, 1995). Increasing evidence has indicated
that cellular redox status modulates various aspects of
cellular events, including proliferation and apoptosis. Human TRX
was initially discovered as an adult T cell leukemia-derived factor
(ADF) produced by human T-cell lymphotropic virus type I-
infected T cells (Tagaya et al, 1989), which upregulate the
interleukin (IL)-2 receptor a-chain and IL-2 (Tagaya et al, 1989;
Yodoi and Uchiyama, 1992). Subsequently, TRX has been shown
to regulate various intracellular molecules via thiol redox control
involving transcription factors such as nuclear factor (NF)-kB,
activator protein 1 (AP-1), myb, redox factor 1, and mitogen-
activated kinase (Abate et al, 1990; Okamoto et al, 1992; Meyer et
al, 1993; Schenk et al, 1994; Hirota et al, 1997; Saitoh et al, 1998).
TRX has been reported to induce AP-1 through de novo
transcription of c-fos and c-jun (Meyer et al, 1993), and TRX
enhances the DNA-binding activity of Jun and Fos (Schenk et al,
1994). TRX is also a stress-inducible protein whose expression is
enhanced by various types of stress, e.g., viral infection, exposure to
ultraviolet (UV) light, X-ray irradiation, and hydrogen peroxide
(H2O2) (Nakamura et al, 1994; Ohira et al, 1994; Sachi et al, 1995).
Furthermore, TRX is a scavenger of reactive oxygen intermediates
(ROI) (Mitsui et al, 1992), and recombinant TRX (rTRX) protects
against cytotoxicity in which the generation of ROI seems to be
involved (Matsuda et al, 1991; Nakamura et al, 1994; Sasada et al,
1996). The sum of these data suggests that TRX plays a number of
important biologic roles in the intracellular and the extracellular
compartments.
We have previously reported that TRX released from UVB-
irradiated keratinocytes acts as one factor that stimulates melano-
genesis by upregulating MSH receptor mRNA expression and
binding activity in melanocytes (Funasaka and Ichihashi, 1997). We
have also shown that the MSH receptor gene, termed melanocortin
1 receptor (MC1-R), is expressed not only in melanocytes, but also
in normal human keratinocytes, and that its expression is further
upregulated in differentiated keratinocytes (Chakraborty et al,
1999). Another group has shown that a-melanocyte stimulating
hormone (a-MSH) renders differentiated keratinocytes more
sensitive to oxidative stress (Orel et al, 1997). This indicates that
differentiated keratinocytes are more reactive to a-MSH through
upregulated MC1-R expression or by enhanced signal transduction
after binding of a-MSH to its receptor. As TRX is known to
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upregulate MC1-R expression by melanocytes, an interesting
question and the aim of this study is to determine whether TRX
also upregulates MC1-R expression and modulates UVB-induced
proopiomelanocortin (POMC) mRNA expression in keratino-
cytes. Furthermore, we used neutralizing TRX antibodies and/or
recombinant TRX (rTRX) to examine the overall effects of TRX
on survival of keratinocytes.
MATERIALS AND METHODS
Cell culture Normal human keratinocytes were established in culture
from foreskins of 18±40-y-old Japanese males. Keratinocytes were grown
in keratinocyte serum free medium (SFM; Gibco Life Technologies,
Grand Island, NY) containing 50 mg bovine pituitary extract (BPE) per
ml and 5 ng recombinant epidermal growth factor (EGF) per ml.
Normal human melanocytes were established from foreskins in culture
and maintained in Ham's F-10 medium supplemented with 5% fetal calf
serum, 85 nM TPA, 0.1 mM IBMX, 1.0 mM insulin, and 40 mg protein
per ml pituitary extract (Funasaka et al, 1992).
Ultraviolet irradiation For UVB irradiation, a bank of ®ve
¯uorescent sunlamps (Toshiba FL20SE, Toshiba Medicals) emitting 280±
370 nm (mainly UVB energy with a peak at 305 nm) was used. Prior to
UVB irradiation, the culture medium was replaced with 0.2 ml (for 6-
well plates) or 1 ml (for 10 cm dishes) of prewarmed phosphate buffered
saline (PBS). Immediately after the UVB irradiation, PBS was removed
and culture medium was added back to the cells, which were further
incubated for 12, 18, 24, or 48 h. Flux intensity was measured with a
UVR-305/365D digital radiometer (Opto-Electronic Measuring
Instruments, Tokyo Optical, Tokyo, Japan).
Cell treatment rTRX (10 mg per ml, provided by Ajinomoto
Kawasaki, Japan) and N-acetylcysteine (NAC, 300 mM, Sigma, IL) were
also used in these experiments.
Reverse transcription-polymerase chain reaction (RT-
PCR) Keratinocytes were seeded in 10 cm dishes in medium as
described above. Eighteen and 24 h after UVB irradiation at 25 mJ per
cm2, or after treatment with rTRX or NAC, total RNA was extracted
using the ISOGEN solution (Nippon Gene, Toyama, Japan) following
the manufacturer's instructions. To examine the effects of pretreatment
with rTRX and NAC, these chemicals were added 1 h prior to UVB
irradiation, and were then incubated for another 18 or 24 h. For the
RT-PCR assays, 5 mg of total RNA was reverse transcribed using oligo
(dT) as primers and Moloney Murine Leukemia Virus Reverse
Transcriptase (Gibco Life Technologies). For quantitative PCR, a
control gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was
ampli®ed. Only samples that were proven to be free from DNA
contamination by running PCR ampli®cation with GAPDH primers but
without prior RT were used for the experiments. Oligonucleotides used
were (a) 5¢-GTC TCT GAA TCA GAA ATC CTT CTA TC-3¢
(sense), and 5¢-CAT GTC AAA TTT CAC TGC TTC ATC-3¢
(antisense) for GAPDH (Slater et al, 1998); (b) 5¢-GAG GGC AAG
CGC TCC TAC TCC-3¢ (sense), and 5¢-GGG GCC CTC GTCCTT
CTT CTC-3¢ (antisense) for POMC (Slominski et al, 1995); and (c) 5¢-
GCC ACC ATG CCA AGA ACC-3¢ (sense) and 5¢-ATA GCC AGG
AAG AAGCCA-3¢ (antisense) for MC1-R (Bhardwaj et al, 1997).
Samples for PCR contained 5 mL of the cDNA (corresponding to
0.5 mg of total RNA), 25 units per ml AmpliTaq DNA polymerase
(Perkin-Elmer, CA), 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, dATP, dCTP, dGTP, dTTP (200 mmol each), and 100 pmol of
the sense and antisense primers. The ®nal reaction volume was 50 mL.
Samples were heated for 5 min at 94°C and were then ampli®ed for 35
cycles at 94°C, 51°C (for MC1-R) or 55°C (for POMC) and 72°C (45 s
each). For GAPDH, the samples were ampli®ed for 22 cycles at 94°C,
55°C, and 72°C (45 s each). After a ®nal extension at 72°C for 10 min,
10 mL of the PCR products were separated in 1.5% agarose gels, stained
with ethidium bromide and photographed under UV.
Northern blot analysis Keratinocytes were treated as described in the
section for RT-PCR. Twelve and 24 h after treatment, total cellular
RNA was extracted. Sixty micrograms of total RNA was size-fractionated
on 1% agarose/formaldehyde gels, blotted onto cellulose nitrate
membranes (Schleicher and Schuell, Dassel, Germany), and UV cross-
linked. The blots were prehybridized for 1 h at 42°C in 40% formamide/
10% Denhardt's solution/4 3 SSC/7 mM Tris-HCl, pH 7.4/20 mg per
ml sheared salmon sperm DNA and were then hybridized at 42°C
overnight with the radiolabeled probes. The coding region of hMC1-R,
cloned from a human genomic EMBL3 phage library (Gantz et al, 1993),
was random prime-labeled with [a-32P]dCTP (Amersham, Bucks, U.K.).
The membranes were washed twice for 15 min at 23°C in 2 3 SSC,
0.1% sodium dodecyl sulfate (SDS) and then once in 0.1 3 SSC, 0.1%
SDS for 30 min at 65°C; blots were then exposed to a phosphor-imaging
plate for 1 h. As an internal loading control, membranes were
rehybridized with human b-actin cDNA (Clontech Laboratory, Palo Alto,
CA), which had been random prime-labeled with [a-32P]dCTP.
Radioactivity on membranes was quanti®ed with a phosphorimage
analyzer (BAS2000; Fuji Photo Film, Kanagawa, Japan). MC1-R mRNA
levels were normalized against the b-actin mRNA signals and
phosphorimager count ratios were calculated. Autoradiograms were
developed by exposing membranes to X-ray ®lm at ±80°C for 1±3 d.
a-MSH binding assay Keratinocytes were seeded in 6-well plates.
Twelve, 24, or 48 h after UVB irradiation or TRX treatment, the a-
MSH binding assay was performed as described previously (Funasaka et
al, 1998). 125I-labeled [Nle4,D-Phe7]a-MSH (Peninsula Laboratory,
Belmont, CA) was used as a ligand. Normal human keratinocytes were
incubated with 90 000 cpm radioligand per 600 mL incubation buffer
(NaCl, 140 mM; KCl, 5 mM; Na2HPO4, 10 mM; KH2PO4, 1 mM;
glucose, 0.1%) at 10°C for 2 h. Non-speci®c binding was assessed by
adding 2 mM unlabeled [Nle4,D-Phe7]a-MSH. After incubation, the
plates were put on ice and washed three times with ice-cold PBS(±).
Cells were detached with 1 ml 1 N NaOH and were measured for
radioactivity in a gamma-counter. Speci®c counts were evaluated by
subtracting the nonspeci®c counts from the total counts.
Extraction of proopiomelanocortin (POMC) peptides For
extraction of peptides, conditioned culture media were pooled separately
for each condition tested, protease inhibitors (aprotinin, 0.01%; PMSF
1 mM) were added, and the media were centrifuged at 16 000 3 g for
30 min. The supernatants were collected, and according to the
manufacturer's protocol (Peninsula Laboratory), peptide extraction was
carried out as follows. An equal volume of peptide extraction buffer A
(provided with the kit, Peninsula, Cat. No. RIK-BA-1), containing 0.1%
tri¯ouroacetic acid (TFA), was added and centrifuged at 3000 3 g for
10 min at 4°C. The supernatants were then passed through a pre-
equilibrated SEP-column containing 200 mg of C18 (Cat. No. RIK-
SEPCOL 1, Peninsula Laboratory). After washing the column with
buffer A, the peptides were eluted with 3 ml of buffer B (60%
acetonitrile in 0.1% TFA, Cat. No. RIK-BB-1) and eluates were
concentrated to dryness in a centrifugal concentrator. The residues were
dissolved in 500 mL RIA buffer (NaH2PO4, 19 mM; Na2HPO4,
81 mM; pH 7.4; NaCl, 0.05 M; BSA, 0.1%; Triton X-100, 0.1%;
NaN3, 0.01%) for the assays of a-MSH and adrenocorticotropic
hormone (ACTH) by the kit method (Peninsula Laboratory).
Cell pellets were dissolved in 1 ml RIA buffer supplemented with 1%
TX-100 and PMSF (1 mM), and aprotinin (0.01%), and processed as
above for peptide isolation through the SEP column.
Radioimmunoassays of a-MSH and ACTH Keratinocytes were
seeded in 6-well plates and irradiated with UVB at 25 mJ per cm2, or
treated with rTRX or NAC for 24 h. For pretreatment of rTRX and
NAC, these chemicals were added 1 h before UVB irradiation, then
incubated for another 24 h. These assays were done using a commercial
radioimmunoassay kit (Peninsula Laboratory). The antisera are highly
speci®c as cross-reactivities among the various POMC peptides, such as
desacetyl-a-MSH, diacetyl-a-MSH, and deamido-a-MSH; b-MSH,
g-MSH, ACTH, or a,b,g-endorphin, were less than 0.01% for rabbit
antia-MSH according to the kit's speci®cations, and as measured directly
with peptide standards in our laboratory. Likewise, the rabbit anti-
ACTH (1±24) serum does not cross-react with other POMC peptides,
such as ACTH (1±10), ACTH (1±13), or a-MSH (cross-reactions were
less than 0.01%), but shows 100% reactivity with human ACTH (1±24)
or ACTH (1±39). Assay procedures were followed according to the kit's
instructions. Brie¯y, 100 mL of the dissolved material was incubated for
24 h with the antibodies against a-MSH or ACTH followed by re-
incubation with 125I-a-MSH or 125I-ACTH for the next 24 h. The
bound 125I-peptide was precipitated with goat antirabbit IgG (GARGG)
and normal rabbit serum. The tubes were then centrifuged at 3000 3 g
for 20 min at 4°C. The supernatants were discarded and pellets were
counted in a gamma-counter. The concentrations of the a-MSH or
ACTH were estimated according to the standard curves prepared for
both peptides, in which known quantities of puri®ed a-MSH or ACTH
were used to compete for 125I-a-MSH and 125I-ACTH binding to the
antibodies. Values of a-MSH and ACTH contents were normalized to
cell number, and levels are expressed as pg per 0.5 3 106 cells or pg per
ml medium for intracellular and culture medium levels, respectively.
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Experiments were repeated three times in quadruplicate, and for
statistical analysis the values were calculated as a percentage of control.
Immunocytochemistry To make cocultures of keratinocytes and
melanocytes, keratinocytes were ®rst seeded in 8-well chamber slides
(Nunc, Naperville, IL), then 24 h later, melanocytes were seeded on the
keratinocytes in the keratinocyte medium at a density of one-seventh of
that of keratinocytes. The next day, cells were irradiated with UVB at
the dose of 0 (sham-irradiation), 10, or 20 mJ per cm2, and monoclonal
TRX antibody (ADF11, provided by Fujirebio, Tokyo, Japan) was
added at concentrations of 0.35 or 2.0 mg per ml. As a control antibody,
OKM 5 (mouse monoclonal antibody against human monocytes, Ortho
Diagnostic Systems, NJ) was used at the same concentrations as the
TRX antibody. To clearly visualize melanocytes, they were reacted with
DOPA, followed by hematoxylin staining 5 d after UVB irradiation, and
the con®guration of melanocytes and keratinocytes were observed under
microscopy. For DOPA reaction, cells were incubated with 5 mM L-
DOPA in PBS(±) and incubated in the dark for 4 h at 37°C.
Statistical analysis Data are shown in Tables I±III as means 6 SD
of three separate experiments (two experiments in the case of Table I).
Statistical analyzes were performed using the two-tail paired t test with
the help of the STATVIEW program (Abacus Concepts, Berkeley, CA).
RESULTS
MC1-R mRNA expression and MSH receptor activity
Semiquantitative RT-PCR assay (35 cycles) showed that both
TRX and NAC, as well as UVB, stimulated the expression of the
MSH receptor (MC1-R) transcript (a 580 bp product), whereas no
signi®cant changes were found in the concentration of an ampli®ed
fragment of GAPDH used as an internal control. Pretreatment with
TRX or NAC did not suppress the UVB-induced MC1-R
expression. Similar results were obtained from northern blotting
experiments of MC1-R after TRX and UVB treatment. The
MC1-R mRNA transcript migrated as a 4 kb species, as reported
previously (Mountjoy et al, 1992; Chakraborty et al, 1999), and that
too was stimulated in human keratinocytes following TRX and
UVB treatment (Fig 1).
We next examined whether TRX increased the binding of MSH
to its keratinocyte surface receptor following UVB irradiation, as
previously reported (Chakraborty et al, 1999). Treatment with
TRX upregulated MSH binding 1.5-fold compared with controls
(Table I). Because of the small number of MSH receptors and the
limited availability of its ligand, 125I-labeled-[Nle4, D-Phe7]-a-
MSH, we could not perform Scatchard analyzes; however,
upregulation of MC1-R mRNA and binding of the ligand to
that receptor suggests that TRX upregulates the number of MSH
receptors, although the possibility of simply enhancing receptor
af®nity cannot be excluded at this time.
POMC mRNA expression Semiquantitative RT-PCR assay
(35 cycles) showed that 24 h after UVB irradiation at 25 mJ per
cm2, the expression of the POMC transcript by normal human
keratinocytes in culture was upregulated; however, no signi®cant
change was observed following treatment with TRX or NAC, or
in pretreatment with these chemicals prior to UVB irradiation
(Fig 2). Samples taken 18 h after UVB irradiation or chemical
Table I. Effect of UVB and TRX on MSH receptor
binding activity in normal human keratinocytesa
125Ia-MSH binding activity
Treatment in culture
(Speci®c binding
per 106 cells) % of control
None 1110 6 461 100 6 15
UVB 25 mJ per cm2
12 h 1533 6 267* 138 6 24
24 h 3538 6 1112** 318 6 100
48 h 4397 6 1197** 396 6 107
TRX (10 mg per ml)
12 h 1694 6 120** 152 6 11
24 h 1641 6 127* 147 6 18
48 h 1665 6 90** 150 6 8
aNormal human keratinocytes were cultured with TRX (10 mg per ml) or
exposed to UVB (25 mJ per cm2) for the indicated time period. Cells were washed
with PBS(±), and 125I-NDP-a-MSH binding assays were carried out as described
in Materials and Methods. Each data point represents the mean 6 SD of three assays
from a representative experiment. The experiments were done twice with similar
results. *p < 0.05; **p < 0.001.
Figure 1. Expression of MC1-R gene by normal human
keratinocytes after treatment with UVB, NAC, and/or TRX. (A)
Detection of MC1-R mRNA by semiquantitative RT-PCR in normal
human keratinocytes treated with UVB, TRX, and their combination.
Upper panel: 580 bp MC1-R mRNA (arrow) was ampli®ed (35 cycles)
using primers as described in the Materials and Methods. The lower panel
shows ampli®cation of the GAPDH gene. DNA size marker, M;
untreated human keratinocytes (lane 1); human keratinocytes exposed to
UVB, 25 mJ per cm2 (lane 2); human keratinocytes treated with TRX,
10 mg per ml (lane 3); human keratinocytes pretreated with TRX, 10 mg
per ml and exposed to UVB, 25 mJ per cm2 (lane 4); human
keratinocytes treated with NAC 300 mM (lane 5); human keratinocytes
pretreated with NAC, 300 mM and exposed to UVB 25 mJ per cm2
(lane 6). All samples were collected 24 h after treatment. (B) Northern
blotting of MC1-R (upper panel) and b-actin (lower panel). Untreated
human keratinocytes (lane 1); human keratinocytes exposed to UVB, 25
mJ per cm2 (lanes 2, 3); human keratinocytes treated with TRX, 10 mg
per ml (lanes 4, 5); human keratinocytes pretreated with TRX, 10 mg
per ml for 1 h and exposed to UVB, 25 mJ per cm2 (lane 6). Samples
were collected 12 h (lanes 2, 4) and 24 h (lanes 3, 5, 6) after treatment.
Q12
34 FUNASAKA ET AL JID SYMPOSIUM PROCEEDINGS
treatment showed similar results (data not shown). The size of the
product (260 bp) was equal to that predicted from primer
sequences, and migrated identically with a POMC transcript run
in parallel as a positive control (not shown). The concentration of
the ampli®ed fragment of the GAPDH transcript, used as an
internal control, remained unchanged during all treatments, and no
products were found in control RNA samples ampli®ed without
previous reverse transcription. We conclude that the ampli®ed
260 bp product represents exon 3 of the POMC gene, results that
are in good agreement with earlier reports (Schauer et al, 1994;
Slominski et al, 1995; Chakraborty et al, 1996).
Effect of UVB, TRX, and NAC on production and release of
a-MSH and ACTH by normal human keratinocytes UVB
irradiation upregulated the production and the secretion of a-MSH
and ACTH by normal human keratinocytes in culture (Table II).
No signi®cant changes in intracellular or extracellular levels of
POMC peptides were observed in TRX- or NAC-treated cells;
however, pretreatment of these chemicals prior to UVB irradiation
suppressed UVB-induced POMC production and secretion
(Table II).
The effect of TRX on cell survival Addition of TRX
antibody to the keratinocyte-melanocyte coculture caused the
death of both types of cells in a concentration-dependent manner,
whereas a control antibody showed no such effect (Fig 3c).
Figure 3(b) shows cells stained 5 d after addition of the TRX
antibody at 2 mg per ml. This cell death could be rescued by adding
rTRX at 5 mg per ml at the same time as the TRX antibody
(Fig 3d). These results indicate that TRX in the cell environment
is essential for cell survival. Five days after UVB irradiation at 10 mJ
per cm2, the addition of TRX antibody did not induce signi®cant
cell death, possibly because the low dose of UVB irradiation
induced production and release of TRX by keratinocytes,1 and thus
cell surface TRX was not signi®cantly neutralized by TRX
antibody (Fig 3f). Furthermore, when cells were irradiated by
UVB at 20 mJ per cm2, the TRX antibody induced cell death
(Fig 3h), but the control antibody had no effect (Fig 3i). It may be
plausible that higher doses of UVB impair the cell environmental
redox state, or that pyrimidine dimers and other DNA damage
produced by direct effect of UVB radiation play a critical role in
cell death.
DISCUSSION
The human epidermis represents the ®rst line of defense against
invading free radicals, and therefore the surface of the skin must be
able to counteract the penetration of UV light as well as to
neutralize reactive oxygen products (Schallreuter and Wood,
1989). Consequently, the human epidermis contains a variety of
antioxidants that can reduce oxygen radicals and hydrogen
peroxide. One such antioxidant, TRX, has been shown to have
a multibiologic function in intracellular and in extracellular
compartments (Takagi et al, 1999). In this study, we have examined
the extracellular effects of TRX on keratinocytes. TRX promotes
the differentiation of melanocytes by upregulating MC1-R
expression (Funasaka and Ichihashi, 1997; Funasaka et al, manu-
script in preparation). a-MSH has been shown to modulate
proliferation and differentiation (Slominski et al, 1991, 1993), as
well as heat shock protein expression, of normal human
keratinocytes, resulting in keratinocytes being more sensitive to
oxidative stress (Orel et al, 1997). Thus, as TRX might work as a
cytoprotective peptide, our primary hypothesis was that TRX
would not increase MC1-R expression in keratinocytes, but in fact
we found that MC1-R expression as well as MSH receptor binding
ability was upregulated by TRX. Because MC1-R intercellular
signaling is activated after binding its ligand POMC peptide, TRX
Table II. Effect of UVB, TRX, and/or NAC, on a-MSH and ACTH synthesis and release by normal human keratinocytesa
a-MSH ACTH
Treatment
Cellular
(pg per 0.5 3 106 cells)
Medium
(pg per ml)
Cellular
(pg per 0.5 3 106 cells)
Medium
(pg per ml)
None 32.5 6 7.1 11.7 6 1.3 20.6 6 2.6 8.1 6 1.8
UVB (25 mJ per cm2) 57.3 6 1.1** 32.8 6 2.5* 52.3 6 3.1** 21.8 6 2.1**
NAC (300 mM) 24.9 6 3.9 13.8 6 1.1 22.9 6 1.2 9.4 6 2.5
NAC + UVB 31.9 6 1.1 15.1 6 1.2 25.8 6 3.3 8.6 6 3.1
TRX (10 mg per ml) 31.3 6 21.3** 13.6 6 1.4 19.4 6 1.3 10.3 6 2.7
TRX + UVB 32.8 6 12.7 12.3 6 1.2 13.1 6 1.5** 7.5 6 3.1*
aa-MSH and ACTH were measured using a commercial RIA kit (Peninsula). Values of a-MSH and ACTH content were normalized to cell number and expressed as
pg per 0.5 3 106 cells (intracellular level); pg per ml medium (released to the medium). Each data point represents the mean 6 SD of two assays from a representative ex-
periment. The experiments were repeated three times with similar results. The statistical analysis of these data was done using the two-tailed paired t test (Abacus,
STATVIEW Program). p < 0.05, **p < 0.001.
Figure 2. Detection of POMC mRNA by semiquantitative RT-
PCR in normal human keratinocytes treated with UVB, TRX,
and/or NAC. Upper panel: 260 bp POMC mRNA from exon 3 (arrow)
was ampli®ed (35 cycles) using primers described in Materials and
Methods. The lower panel shows ampli®cation of the GAPDH gene as
control. DNA size marker, M; untreated human keratinocytes (lane 1);
human keratinocytes exposed to UVB, 25 mJ per cm2 (lane 2); human
keratinocytes treated with TRX, 10 mg per ml (lane 3); human
keratinocytes pretreated with TRX, 10 mg per ml for 1 h and exposed
to UVB, 25 mJ per cm2 (lane 4); human keratinocytes treated with
NAC, 300 mM (lane 5); human keratinocytes pretreated with NAC,
300 mM for 1 h and exposed to UVB, 25 mJ per cm2 (lane 6). All
samples were collected 24 h after treatment.
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might be controlling the survival of keratinocytes by suppressing
the production and secretion of POMC peptides by keratinocytes.
The target of UV damage is not only DNA but also membrane
and cytoplasmic compounds. Oxidative stress at or near the plasma
membrane has been reported to initiate UV responses, leading to
the activation of Src, Ras, Raf-1, and AP-1 complex (Devary et al,
1992). We showed that TRX as well as NAC, suppresses the UVB-
induced expression of the POMC gene as well as the production
and secretion of its products, a-MSH and ACTH, in keratinocytes.
Although modulation of POMC expression by agents such as
interleukin-1 (IL-1), dibutyryl cyclic AMP (dbcAMP), 12-O-
tetradecanoylphorbol-13-acetate (TPA), UVB (Schauer et al, 1994;
Chakraborty et al, 1996), and corticotropin releasing hormone
(CRH) (Slominski et al, 1998; Funasaka et al, 1999), have been
reported, the molecular mechanism(s) of inducing POMC gene
expression is not known. NAC is readily taken up by cells and is
rapidly converted to glutathione (GSH). TRX enhances the
internalization of L-cystine into cells and elevates the intracellular
GSH content (Iwata et al, 1997). NF-kB is stored as an inactive
cytoplasmic complex in association with IkB. When activation
signals reach the IkB kinase complex, IkB is phosphorylated by IkB
kinases and is then degraded and dissociated from NF-kB; it is this
free NF-kB complex that translocates from the cytoplasm into the
nucleus (Hirota et al, 1999). Cytoplasmic GSH inhibits phos-
phorylation of IkB by activating phosphatase, and thus GSH
inhibits the nuclear transport of NF-kB. Although whether the
POMC gene is activated by NF-kB is not clear at present, the
inhibitory effect of TRX and NAC on POMC gene induction by
UVB might involve increases in cytoplasmic GSH levels as both
NAC and TRX enhance cytoplasmic GSH concentrations. The
possibility of POMC gene induction by NF-kB is now being
investigated in our laboratory.
To con®rm the overall effect of extracellular TRX on
keratinocyte survival, a neutralizing antibody was added to the
culture medium. Addition of the TRX antibody to the
keratinocyte-melanocyte coculture caused the death of both cell
types in a concentration-dependent manner. This cell death could
be rescued by addition of rTRX, which indicates that TRX is
essential for cell survival in the epidermal melanin unit. The known
cellular protective effects of TRX include: (1) protecting
endothelial cell injury caused by activated neutrophils or hydrogen
peroxide (Nakamura et al, 1994); (2) protecting U-937 monocytes
from TNF or Fas antibody induced cell toxicity (Matsuda et al,
1991), the mechanism of which would involve the cooperative
action of cytoplasmic TRX reductase and TRX peroxidase; and (3)
preventing apoptosis of lymphoid cells induced by L-cystine and
GSH depletion, via direct scavenging of H2O2 (catalase activity)
and hydroxy radicals or indirectly neutralizing pro-oxidant status by
enhancing L-cystine internalization and elevating the intracellular
GSH content (Iwata et al, 1997). Another mechanism is that TRX
induces manganese superoxide dismutase (MnSOD) expression,
resulting in the mutual and cooperative action of SOD and TRX
peroxidase against oxidative stress (Das et al, 1997). It is thus very
plausible that extracellular TRX is essential to regulate redox
potential for cell survival.
In conclusion, our data suggest that TRX has diverse biologic
functions. In addition to modulating gene expression of MC1-R
and POMC, extrinsic TRX sustains cell viability in the epidermal
melanin unit. Stress-inducible TRX and neuropeptides might
regulate cell survival by affecting each other in the skin.
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and Scienti®c Research on Priority Areas Cancer (12213080), from the Japanese
Figure 3. Immunocytochemistry of UVB-irradiated keratinocytes and melanocytes. (a) Five days after sham irradiation, DOPA and
hematoxylin staining was performed on the keratinocyte-melanocyte coculture system. (b) Monoclonal TRX antibody (ADF11) was added at a
concentration of 2 mg per ml to the keratinocyte-melanocyte coculture for 5 d. (c) Control antibody (IgG1) was added at a concentration of 2 mg per
ml to the keratinocyte-melanocyte coculture for the same period as (b). (d) Monoclonal TRX antibody (ADF11) at a concentration of 2 mg per ml and
rTRX at a concentration of 5 mg per ml were added to the keratinocyte-melanocyte coculture for 5 d. (e) UVB was used to irradiate the keratinocyte-
melanocyte coculturing system at the concentration of 10 mJ per cm2, and 5 d after the irradiation, the cells were stained. (f) UVB was used to
irradiate the keratinocyte-melanocyte coculture at a concentration of 10 mJ per cm2, and immediately after UVB irradiation, monoclonal TRX
antibody (ADF11) was added at the concentration of 2 mg per ml for 5 d. (g) UVB was used to irradiate the keratinocyte-melanocyte coculture at a
concentration of 20 mJ per cm2, and 5 d after the irradiation, the cells were stained. (h) UVB was used to irradiate the keratinocyte-melanocyte
coculture at a concentration of 20 mJ per cm2, and immediately after UVB irradiation, monoclonal TRX antibody (ADF11) was added at a
concentration of 2 mg per ml for 5 d. (i) UVB was used to irradiate the keratinocyte-melanocyte coculture at a concentration of 20 mJ per cm2;
immediately after UVB irradiation, control antibody (IgG1) was added at a concentration of 2 mg per ml for 5 d.
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